PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European shares end week higher as Pfizer pill lifts travel stocks

Fri, 05th Nov 2021 10:12

* STOXX 600 marks fifth week of gains

* Pfizer COVID-19 pill turbo-charges travel stocks

* Allegro surges after Mall Group deal

* German, French stocks scale new peaks
(Adds comments, updates prices throughout)

By Shreyashi Sanyal

Nov 5 (Reuters) - European equities wrapped up another week
of gains on Friday, led by advances in travel stocks after a
positive update from U.S. drugmaker Pfizer on its pill for
COVID-19 and amid persistent optimism about earnings season.

The pan-European STOXX 600 ended flat, but clocked
1.7% in weekly gains, its fifth consecutive week in the green.

European travel stocks jumped 1.4% as investors
across the globe cheered Pfizer Inc's trial of an
experimental antiviral pill for COVID-19, which was shown to cut
risk of developing severe disease by 89%.

The news lifted shares of Swiss duty free retailer Dufry
by 10.1%, to its best day since November 9, 2020, while
also pushing down shares of AstraZeneca.

"Today's news out of the U.S. that Pfizer has developed a
COVID-19 pill, which is 89% effective in preventing
hospitalisation, may well be weighing on the AstraZeneca share
price a touch, but it has pretty much turbo-charged the airlines
and hospitality sector," said Michael Hewson, chief market
analyst at CMC Markets.

Dovish moves by the U.S. Federal Reserve and the Bank of
England, and similar comments from the European Central Bank
chief have helped sentiment this week.

Data from the U.S. Labor Department showed employment
increased more than expected in October as the headwinds from a
surge in COVID-19 infections over the summer subsided, also
supporting the day's upbeat mood.

On Friday, France's benchmark CAC 40 index breached
the 7,000 points barrier for the first time ever, and was up
0.8%.

The blue-chip index was led by gains in Kering,
Hermes and L'Oreal.

Germany's DAX reversed early declines to scale
fresh peaks, as investors shrugged off disappointing industrial
output data in Europe's biggest economy.

Gains in the STOXX 600 were led by Allegro, which
surged 10.6% after the Polish e-commerce group agreed to buy
Czech online retailer Mall Group for 881 million euros.

Spain's CaixaBank also rose 1.6% after saying it
had sold its entire 9.92% stake in Austrian bank Erste Group
for 1.503 billion euros. Erste added 5%.

A rebound in London-listed banks, which dropped after the
Bank of England's move on Thursday to hold rates, saw London's
FTSE 100 gain 0.3%.
(Reporting by Anisha Sircar, Susan Mathew and Shreyashi Sanyal
in Bengaluru; Editing by Shounak Dasgupta, William Maclean)

More News
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.